Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
about
Planarians as a model to assess in vivo the role of matrix metalloproteinase genes during homeostasis and regenerationMatrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTUREMatrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP ComplexesTotal conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzymeAffinity- and specificity-enhancing mutations are frequent in multispecific interactions between TIMP2 and MMPsInactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria.Progress in matrix metalloproteinase research.Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversityMatrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.Metalloendoprotease cleavage triggers gelsolin amyloidogenesisSelective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3.Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer EffectsMatrix metalloproteinases as breast cancer drivers and therapeutic targets.Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.ADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4.Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cellsMonitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression.Individual Timp deficiencies differentially impact pro-MMP-2 activation.Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
P2860
Q27316472-2F98FC79-76B6-4194-90A1-0E7F92E1A13BQ27678085-C7A5D54B-8907-4BCA-AD43-54D5BE7BE507Q27680082-6B2524A0-0B0F-4EDA-8826-8A050F677118Q28235218-AEDE6004-775C-409F-AB30-D3063F1F3148Q28542042-3610C96C-C104-43F7-83BA-4642814AA8FAQ33581798-6F4463C3-421B-453D-9843-368B1E2CCCACQ33608536-F894AB01-70FA-4E4F-A1A6-D8D789203C3FQ33618445-072140F1-C2D5-4E03-A259-DA1091ED1C6CQ33786342-3FB4F11A-B904-447B-882B-2F0A02581C33Q33915005-2E414EA4-8C7A-4B03-A813-CB248D6E7364Q34324885-5BF7A0F9-E535-42F9-9F43-2B23FDA6A7D9Q34513677-21A5D91F-7B1E-475C-BCF8-778FA438C66AQ34947735-C126F83A-12F7-40F6-97D0-08C84B504C71Q35063432-846729D8-89C4-44B8-B465-3F8919425529Q35755954-F8D53347-BA75-4895-806C-4788116ECFFAQ35892721-55076B14-464F-426A-ACC6-A4DD2F5A4006Q36190097-976C8350-5DB4-4AF6-8EB6-787611B7916AQ36393553-E41ED65F-CB21-46AE-9607-DBD40F5A0FF3Q36502133-122E6779-3BAB-43AE-AF07-C40E3CC83197Q37012504-C0EBF77F-6A01-4D3D-8F83-B243AC4E4051Q37693503-78A32468-A56C-4BE0-84F7-549C795026F0Q40318346-DF3A02D7-1889-4877-BE55-E458B6BC3139Q42720277-BCE1A772-BA69-4794-9223-7B051C4D481DQ44735775-8E93DE76-5112-47D2-B35D-E31D3EE07698Q45016679-B4203EEB-C880-4931-AE0D-52E0D6AB78BEQ51380060-BD92DE9E-A17D-4BB5-9150-7629648FC8AE
P2860
Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Unveiling the surface epitopes ...... pe 1-matrix metalloproteinase.
@en
Unveiling the surface epitopes ...... pe 1-matrix metalloproteinase.
@nl
type
label
Unveiling the surface epitopes ...... pe 1-matrix metalloproteinase.
@en
Unveiling the surface epitopes ...... pe 1-matrix metalloproteinase.
@nl
prefLabel
Unveiling the surface epitopes ...... pe 1-matrix metalloproteinase.
@en
Unveiling the surface epitopes ...... pe 1-matrix metalloproteinase.
@nl
P2093
P2860
P356
P1476
Unveiling the surface epitopes ...... pe 1-matrix metalloproteinase.
@en
P2093
Gillian Murphy
Magdalini Rapti
Meng-Huee Lee
P2860
P304
40224-40230
P356
10.1074/JBC.M305678200
P407
P577
2003-07-17T00:00:00Z